Tenaya Therapeutics (TNYA) EPS (Weighted Average and Diluted) (2021 - 2026)
Tenaya Therapeutics (TNYA) recorded quarterly EPS (Weighted Average and Diluted) of -$0.09 in Q1 2026, up 18.18% quarter-over-quarter from -$0.11 in Q4 2025, and up 62.5% on a YoY basis from -$0.06 in Q1 2025.
Tenaya Therapeutics (TNYA) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Tenaya Therapeutics' EPS (Weighted Average and Diluted) history runs 6 years deep, the most recent figure standing at -$0.09 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 62.5% year-over-year to -$0.09; the TTM figure through Mar 2026 stood at -$0.46 (up 60.0% YoY), while the FY2025 annual figure was -$0.59, up 54.96% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.09 for Q1 2026 at Tenaya Therapeutics, up from -$0.11 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.09 in Q1 2026 to a low of -$0.75 in Q1 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.38 across 5 years, with a median of -$0.39 in 2023.
- The sharpest annual moves came in 2022 and 2026: EPS (Weighted Average and Diluted) plunged 189.23% in 2022, then jumped 62.5% in 2026.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.58 in 2022, then jumped by 31.03% to -$0.4 in 2023, then soared by 32.5% to -$0.27 in 2024, then jumped by 59.26% to -$0.11 in 2025, then gained by 18.18% to -$0.09 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.09 (Q1 2026), -$0.11 (Q4 2025), and -$0.12 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Tenaya Therapeutics | 158.32 Mn | 158.32 Mn | - | -0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.09 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.12 |
| Jun 30, 2025 | -0.14 |
| Mar 31, 2025 | -0.24 |
| Dec 31, 2024 | -0.27 |
| Sep 30, 2024 | -0.30 |
| Jun 30, 2024 | -0.34 |
| Mar 31, 2024 | -0.40 |
| Dec 31, 2023 | -0.40 |
| Sep 30, 2023 | -0.39 |
| Jun 30, 2023 | -0.45 |
| Mar 31, 2023 | -0.43 |
| Dec 31, 2022 | -0.58 |
| Sep 30, 2022 | -0.74 |
| Jun 30, 2022 | -0.69 |
| Mar 31, 2022 | -0.75 |
| Dec 31, 2021 | 0.65 |
| Sep 30, 2021 | -0.68 |